Regulus Therapeutics Inc Capital Reinvestment Ratio
Regulus Therapeutics Inc capital reinvestment ratio. Regulus Therapeutics Inc (RGLS) has a Capital Reinvestment Ratio of 0.07x as of December 2020, meaning it reinvests 0% of its operating cash flow ($3.19 Million) in capital expenditures ($237.00K). Check RGLS capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Regulus Therapeutics Inc (2010–2010)
Capital reinvestment ratio of Regulus Therapeutics Inc from 2010 to 2010. This chart tracks Regulus Therapeutics Inc's Capital Reinvestment Ratio across 1 annual periods. Also explore Regulus Therapeutics Inc annual equity growth to track the company's year-over-year net asset growth rate.
Regulus Therapeutics Inc Capital Reinvestment Ratio by Year (2010–2010)
Regulus Therapeutics Inc capital reinvestment ratio by year from 2010 to 2010. For the full cash flow conversion analysis, see Regulus Therapeutics Inc cash conversion from operations.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2010 | 0.20x | $12.31 Million | $2.42 Million | — |